nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Rash generalised—Progesterone—uterine cancer	0.0503	0.0503	CcSEcCtD
Levobunolol—Rash generalised—Medroxyprogesterone Acetate—uterine cancer	0.0455	0.0455	CcSEcCtD
Levobunolol—Cerebral ischaemia—Medroxyprogesterone Acetate—uterine cancer	0.0401	0.0401	CcSEcCtD
Levobunolol—Nasal congestion—Progesterone—uterine cancer	0.017	0.017	CcSEcCtD
Levobunolol—Visual disturbance—Progesterone—uterine cancer	0.0164	0.0164	CcSEcCtD
Levobunolol—Diabetes mellitus—Medroxyprogesterone Acetate—uterine cancer	0.0162	0.0162	CcSEcCtD
Levobunolol—Diplopia—Progesterone—uterine cancer	0.0155	0.0155	CcSEcCtD
Levobunolol—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.0155	0.0155	CcSEcCtD
Levobunolol—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.0148	0.0148	CcSEcCtD
Levobunolol—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.0144	0.0144	CcSEcCtD
Levobunolol—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.0143	0.0143	CcSEcCtD
Levobunolol—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.0132	0.0132	CcSEcCtD
Levobunolol—Pain—Carboplatin—uterine cancer	0.0124	0.0124	CcSEcCtD
Levobunolol—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.0119	0.0119	CcSEcCtD
Levobunolol—Depression—Progesterone—uterine cancer	0.0119	0.0119	CcSEcCtD
Levobunolol—Conjunctivitis—Progesterone—uterine cancer	0.0116	0.0116	CcSEcCtD
Levobunolol—Lethargy—Dactinomycin—uterine cancer	0.0112	0.0112	CcSEcCtD
Levobunolol—Depression—Medroxyprogesterone Acetate—uterine cancer	0.0108	0.0108	CcSEcCtD
Levobunolol—Visual impairment—Progesterone—uterine cancer	0.0103	0.0103	CcSEcCtD
Levobunolol—Erythema multiforme—Progesterone—uterine cancer	0.0101	0.0101	CcSEcCtD
Levobunolol—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.0099	0.0099	CcSEcCtD
Levobunolol—Alopecia—Progesterone—uterine cancer	0.00948	0.00948	CcSEcCtD
Levobunolol—Keratitis—Epirubicin—uterine cancer	0.00944	0.00944	CcSEcCtD
Levobunolol—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00937	0.00937	CcSEcCtD
Levobunolol—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00919	0.00919	CcSEcCtD
Levobunolol—Cardiac failure congestive—Etoposide—uterine cancer	0.00875	0.00875	CcSEcCtD
Levobunolol—Keratitis—Doxorubicin—uterine cancer	0.00874	0.00874	CcSEcCtD
Levobunolol—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00859	0.00859	CcSEcCtD
Levobunolol—Syncope—Progesterone—uterine cancer	0.00837	0.00837	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00837	0.00837	CcSEcCtD
Levobunolol—Palpitations—Progesterone—uterine cancer	0.00825	0.00825	CcSEcCtD
Levobunolol—Loss of consciousness—Progesterone—uterine cancer	0.00821	0.00821	CcSEcCtD
Levobunolol—Chest pain—Progesterone—uterine cancer	0.00795	0.00795	CcSEcCtD
Levobunolol—Confusional state—Progesterone—uterine cancer	0.00769	0.00769	CcSEcCtD
Levobunolol—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00759	0.00759	CcSEcCtD
Levobunolol—Stinging—Epirubicin—uterine cancer	0.00756	0.00756	CcSEcCtD
Levobunolol—Cardiac arrest—Etoposide—uterine cancer	0.00754	0.00754	CcSEcCtD
Levobunolol—Shock—Progesterone—uterine cancer	0.0075	0.0075	CcSEcCtD
Levobunolol—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00748	0.00748	CcSEcCtD
Levobunolol—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00744	0.00744	CcSEcCtD
Levobunolol—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.0072	0.0072	CcSEcCtD
Levobunolol—Erythema multiforme—Dactinomycin—uterine cancer	0.00717	0.00717	CcSEcCtD
Levobunolol—Hypotension—Progesterone—uterine cancer	0.00712	0.00712	CcSEcCtD
Levobunolol—Stinging—Doxorubicin—uterine cancer	0.007	0.007	CcSEcCtD
Levobunolol—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00696	0.00696	CcSEcCtD
Levobunolol—Paraesthesia—Progesterone—uterine cancer	0.00684	0.00684	CcSEcCtD
Levobunolol—Dyspnoea—Progesterone—uterine cancer	0.0068	0.0068	CcSEcCtD
Levobunolol—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00679	0.00679	CcSEcCtD
Levobunolol—Bronchospasm—Etoposide—uterine cancer	0.00674	0.00674	CcSEcCtD
Levobunolol—Alopecia—Dactinomycin—uterine cancer	0.0067	0.0067	CcSEcCtD
Levobunolol—Pain—Progesterone—uterine cancer	0.00652	0.00652	CcSEcCtD
Levobunolol—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00645	0.00645	CcSEcCtD
Levobunolol—Atrioventricular block—Epirubicin—uterine cancer	0.00632	0.00632	CcSEcCtD
Levobunolol—Feeling abnormal—Progesterone—uterine cancer	0.00628	0.00628	CcSEcCtD
Levobunolol—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.0062	0.0062	CcSEcCtD
Levobunolol—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00616	0.00616	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00606	0.00606	CcSEcCtD
Levobunolol—Urticaria—Progesterone—uterine cancer	0.00605	0.00605	CcSEcCtD
Levobunolol—Atrioventricular block—Doxorubicin—uterine cancer	0.00584	0.00584	CcSEcCtD
Levobunolol—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00569	0.00569	CcSEcCtD
Levobunolol—Hypersensitivity—Progesterone—uterine cancer	0.00562	0.00562	CcSEcCtD
Levobunolol—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00549	0.00549	CcSEcCtD
Levobunolol—Asthenia—Progesterone—uterine cancer	0.00547	0.00547	CcSEcCtD
Levobunolol—Pruritus—Progesterone—uterine cancer	0.00539	0.00539	CcSEcCtD
Levobunolol—Diarrhoea—Progesterone—uterine cancer	0.00521	0.00521	CcSEcCtD
Levobunolol—Erythema multiforme—Etoposide—uterine cancer	0.00519	0.00519	CcSEcCtD
Levobunolol—Diabetes mellitus—Epirubicin—uterine cancer	0.00511	0.00511	CcSEcCtD
Levobunolol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00509	0.00509	CcSEcCtD
Levobunolol—Dizziness—Progesterone—uterine cancer	0.00504	0.00504	CcSEcCtD
Levobunolol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00496	0.00496	CcSEcCtD
Levobunolol—Cardiac failure congestive—Epirubicin—uterine cancer	0.0049	0.0049	CcSEcCtD
Levobunolol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00489	0.00489	CcSEcCtD
Levobunolol—Alopecia—Etoposide—uterine cancer	0.00485	0.00485	CcSEcCtD
Levobunolol—Headache—Progesterone—uterine cancer	0.00477	0.00477	CcSEcCtD
Levobunolol—Diabetes mellitus—Doxorubicin—uterine cancer	0.00473	0.00473	CcSEcCtD
Levobunolol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00473	0.00473	CcSEcCtD
Levobunolol—Pain—Dactinomycin—uterine cancer	0.00461	0.00461	CcSEcCtD
Levobunolol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00457	0.00457	CcSEcCtD
Levobunolol—Hypoglycaemia—Epirubicin—uterine cancer	0.00456	0.00456	CcSEcCtD
Levobunolol—Cerebrovascular accident—Epirubicin—uterine cancer	0.00454	0.00454	CcSEcCtD
Levobunolol—Lethargy—Epirubicin—uterine cancer	0.00454	0.00454	CcSEcCtD
Levobunolol—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00454	0.00454	CcSEcCtD
Levobunolol—Nausea—Progesterone—uterine cancer	0.00453	0.00453	CcSEcCtD
Levobunolol—Diplopia—Epirubicin—uterine cancer	0.00445	0.00445	CcSEcCtD
Levobunolol—Feeling abnormal—Dactinomycin—uterine cancer	0.00444	0.00444	CcSEcCtD
Levobunolol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00433	0.00433	CcSEcCtD
Levobunolol—Cardiac arrest—Epirubicin—uterine cancer	0.00423	0.00423	CcSEcCtD
Levobunolol—Hypoglycaemia—Doxorubicin—uterine cancer	0.00422	0.00422	CcSEcCtD
Levobunolol—Loss of consciousness—Etoposide—uterine cancer	0.0042	0.0042	CcSEcCtD
Levobunolol—Cerebrovascular accident—Doxorubicin—uterine cancer	0.0042	0.0042	CcSEcCtD
Levobunolol—Lethargy—Doxorubicin—uterine cancer	0.0042	0.0042	CcSEcCtD
Levobunolol—Ataxia—Epirubicin—uterine cancer	0.00418	0.00418	CcSEcCtD
Levobunolol—Diplopia—Doxorubicin—uterine cancer	0.00411	0.00411	CcSEcCtD
Levobunolol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0041	0.0041	CcSEcCtD
Levobunolol—Chest pain—Etoposide—uterine cancer	0.00407	0.00407	CcSEcCtD
Levobunolol—Hypersensitivity—Dactinomycin—uterine cancer	0.00397	0.00397	CcSEcCtD
Levobunolol—Confusional state—Etoposide—uterine cancer	0.00393	0.00393	CcSEcCtD
Levobunolol—Cardiac arrest—Doxorubicin—uterine cancer	0.00391	0.00391	CcSEcCtD
Levobunolol—Ataxia—Doxorubicin—uterine cancer	0.00387	0.00387	CcSEcCtD
Levobunolol—Asthenia—Dactinomycin—uterine cancer	0.00387	0.00387	CcSEcCtD
Levobunolol—Diarrhoea—Dactinomycin—uterine cancer	0.00369	0.00369	CcSEcCtD
Levobunolol—Hypotension—Etoposide—uterine cancer	0.00364	0.00364	CcSEcCtD
Levobunolol—Paraesthesia—Etoposide—uterine cancer	0.0035	0.0035	CcSEcCtD
Levobunolol—Dyspnoea—Etoposide—uterine cancer	0.00348	0.00348	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.0034	0.0034	CcSEcCtD
Levobunolol—Pain—Etoposide—uterine cancer	0.00333	0.00333	CcSEcCtD
Levobunolol—Conjunctivitis—Epirubicin—uterine cancer	0.00333	0.00333	CcSEcCtD
Levobunolol—Feeling abnormal—Etoposide—uterine cancer	0.00321	0.00321	CcSEcCtD
Levobunolol—Nausea—Dactinomycin—uterine cancer	0.0032	0.0032	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00314	0.00314	CcSEcCtD
Levobunolol—Bradycardia—Epirubicin—uterine cancer	0.00313	0.00313	CcSEcCtD
Levobunolol—Urticaria—Etoposide—uterine cancer	0.0031	0.0031	CcSEcCtD
Levobunolol—Conjunctivitis—Doxorubicin—uterine cancer	0.00308	0.00308	CcSEcCtD
Levobunolol—Visual impairment—Epirubicin—uterine cancer	0.00296	0.00296	CcSEcCtD
Levobunolol—Erythema multiforme—Epirubicin—uterine cancer	0.00291	0.00291	CcSEcCtD
Levobunolol—Bradycardia—Doxorubicin—uterine cancer	0.0029	0.0029	CcSEcCtD
Levobunolol—Hypersensitivity—Etoposide—uterine cancer	0.00287	0.00287	CcSEcCtD
Levobunolol—Asthenia—Etoposide—uterine cancer	0.0028	0.0028	CcSEcCtD
Levobunolol—Pruritus—Etoposide—uterine cancer	0.00276	0.00276	CcSEcCtD
Levobunolol—Arrhythmia—Epirubicin—uterine cancer	0.00275	0.00275	CcSEcCtD
Levobunolol—Visual impairment—Doxorubicin—uterine cancer	0.00274	0.00274	CcSEcCtD
Levobunolol—Alopecia—Epirubicin—uterine cancer	0.00272	0.00272	CcSEcCtD
Levobunolol—Erythema multiforme—Doxorubicin—uterine cancer	0.00269	0.00269	CcSEcCtD
Levobunolol—Diarrhoea—Etoposide—uterine cancer	0.00267	0.00267	CcSEcCtD
Levobunolol—Dizziness—Etoposide—uterine cancer	0.00258	0.00258	CcSEcCtD
Levobunolol—Arrhythmia—Doxorubicin—uterine cancer	0.00254	0.00254	CcSEcCtD
Levobunolol—Alopecia—Doxorubicin—uterine cancer	0.00252	0.00252	CcSEcCtD
Levobunolol—Headache—Etoposide—uterine cancer	0.00244	0.00244	CcSEcCtD
Levobunolol—Syncope—Epirubicin—uterine cancer	0.0024	0.0024	CcSEcCtD
Levobunolol—Palpitations—Epirubicin—uterine cancer	0.00237	0.00237	CcSEcCtD
Levobunolol—Loss of consciousness—Epirubicin—uterine cancer	0.00235	0.00235	CcSEcCtD
Levobunolol—Nausea—Etoposide—uterine cancer	0.00232	0.00232	CcSEcCtD
Levobunolol—Chest pain—Epirubicin—uterine cancer	0.00228	0.00228	CcSEcCtD
Levobunolol—Syncope—Doxorubicin—uterine cancer	0.00222	0.00222	CcSEcCtD
Levobunolol—Confusional state—Epirubicin—uterine cancer	0.0022	0.0022	CcSEcCtD
Levobunolol—Palpitations—Doxorubicin—uterine cancer	0.00219	0.00219	CcSEcCtD
Levobunolol—Loss of consciousness—Doxorubicin—uterine cancer	0.00218	0.00218	CcSEcCtD
Levobunolol—Shock—Epirubicin—uterine cancer	0.00215	0.00215	CcSEcCtD
Levobunolol—Chest pain—Doxorubicin—uterine cancer	0.00211	0.00211	CcSEcCtD
Levobunolol—Hypotension—Epirubicin—uterine cancer	0.00204	0.00204	CcSEcCtD
Levobunolol—Confusional state—Doxorubicin—uterine cancer	0.00204	0.00204	CcSEcCtD
Levobunolol—Shock—Doxorubicin—uterine cancer	0.00199	0.00199	CcSEcCtD
Levobunolol—Paraesthesia—Epirubicin—uterine cancer	0.00196	0.00196	CcSEcCtD
Levobunolol—Dyspnoea—Epirubicin—uterine cancer	0.00195	0.00195	CcSEcCtD
Levobunolol—Hypotension—Doxorubicin—uterine cancer	0.00189	0.00189	CcSEcCtD
Levobunolol—Pain—Epirubicin—uterine cancer	0.00187	0.00187	CcSEcCtD
Levobunolol—Paraesthesia—Doxorubicin—uterine cancer	0.00182	0.00182	CcSEcCtD
Levobunolol—Dyspnoea—Doxorubicin—uterine cancer	0.0018	0.0018	CcSEcCtD
Levobunolol—Feeling abnormal—Epirubicin—uterine cancer	0.0018	0.0018	CcSEcCtD
Levobunolol—Urticaria—Epirubicin—uterine cancer	0.00174	0.00174	CcSEcCtD
Levobunolol—Pain—Doxorubicin—uterine cancer	0.00173	0.00173	CcSEcCtD
Levobunolol—Feeling abnormal—Doxorubicin—uterine cancer	0.00167	0.00167	CcSEcCtD
Levobunolol—Hypersensitivity—Epirubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Levobunolol—Urticaria—Doxorubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Levobunolol—Asthenia—Epirubicin—uterine cancer	0.00157	0.00157	CcSEcCtD
Levobunolol—Pruritus—Epirubicin—uterine cancer	0.00155	0.00155	CcSEcCtD
Levobunolol—Diarrhoea—Epirubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Levobunolol—Hypersensitivity—Doxorubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Levobunolol—Asthenia—Doxorubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Levobunolol—Dizziness—Epirubicin—uterine cancer	0.00145	0.00145	CcSEcCtD
Levobunolol—Pruritus—Doxorubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Levobunolol—Diarrhoea—Doxorubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Levobunolol—Headache—Epirubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Levobunolol—Dizziness—Doxorubicin—uterine cancer	0.00134	0.00134	CcSEcCtD
Levobunolol—Nausea—Epirubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Levobunolol—Headache—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Levobunolol—Nausea—Doxorubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
